Last Updated:
Name Designation Appointment Date Status
Manesh Thomas

Appointed as Director since June 2018

 Director 05-Jun-2018 Current
Premium access

Complete director details

Unlock the complete director and KMP records available for Coptic Pharmaceuticals Private Limited.

  • Complete appointment and designation records
  • Current and past company associations
  • Shareholding and remuneration where filed

Verified entity values are shown only after access is granted.
Chinmayee Maneesh

Appointed as Director since June 2018

 Director 05-Jun-2018 Current
Biju Devassy

Appointed as Managing Director since March 2024

 Managing Director 23-Mar-2024 Current
Kanakappilly Valappil Peter Dani Pius

Appointed as Director since March 2024

 Director 23-Mar-2024 Current

People Timeline

Explore the timeline of key personnel in Coptic Pharmaceuticals Private Limited's leadership journey.

Contact Details
  • Address Xxi/471 B 26 R .S Road, Chalakudy Kerala, 680307, India
  • Telephone Upgrade
  • Email Upgrade
  • Pin Code 680307
  • Country India
  • Website -
Frequently Asked Questions
You can contact Coptic Pharmaceuticals Private Limited through their registered address at Xxi/471 B 26 R .S Road, Chalakudy Kerala, 680307, India, or via their website if available. Social media links are also provided where applicable.
The current directors of Coptic Pharmaceuticals Private Limited are listed above in the "Current Directors & Signatories" section. You can view their names, designations, and appointment dates.
  • MANESH THOMAS
  • CHINMAYEE MANEESH
  • Biju Devassy
  • Kanakappilly Valappil Peter Dani Pius
Past director details are available under the "Past Directors & Signatories" tab. You may need to upgrade your subscription to view detailed information.
Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available